See more : Quess Corp Limited (QUESS.BO) Income Statement Analysis – Financial Results
Complete financial analysis of MustGrow Biologics Corp. (MGROF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of MustGrow Biologics Corp., a leading company in the Agricultural Inputs industry within the Basic Materials sector.
You may be interested
- Biocure Technology Inc. (CURE.CN) Income Statement Analysis – Financial Results
- Haw Par Corporation Limited (H02.SI) Income Statement Analysis – Financial Results
- Schneider National, Inc. (SNDR) Income Statement Analysis – Financial Results
- Avidbank Holdings, Inc. (AVBH) Income Statement Analysis – Financial Results
- Aquestive Therapeutics, Inc. (AQST) Income Statement Analysis – Financial Results
MustGrow Biologics Corp. (MGROF)
About MustGrow Biologics Corp.
MustGrow Biologics Corp., an agricultural biotech company, focuses om development and commercialization of natural biopesticide, biofumigants, and bioherbicides derived from mustard seed. It provides preplant soil biofumigation, a technology to treat soil-borne diseases and pests for various crops, including fruit, vegetables, and other crops. The company is also developing bioherbicide to treat unwanted plant growth for use in organic agriculture, home, and garden markets, as well as agriculture markets; and postharvest food preservation, an application in sprout, disease, and pathogen treatment for storage and food preservation markets. In addition, it focuses on providing CannaPM, an active ingredient to treat fungal soil diseases, as well as foliar diseases. The company was formerly known as Duport Capital Ltd. and changed its name to MustGrow Biologics Corp. in March 2018. MustGrow Biologics Corp. was incorporated in 2014 and is headquartered in Saskatoon, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.71M | 6.48K | 12.87K | 0.00 | 0.00 | 2.00K | 2.10K | 109.02K | 12.42K |
| Cost of Revenue | 384.69K | 298.21K | 203.59K | 187.68K | 74.19K | 44.74K | 48.71K | 21.26K | 75.80K |
| Gross Profit | 4.33M | -291.73K | -190.72K | -187.68K | -74.19K | -42.74K | -46.60K | 87.76K | -63.38K |
| Gross Profit Ratio | 91.84% | -4,502.72% | -1,482.03% | 0.00% | 0.00% | -2,136.90% | -2,217.13% | 80.50% | -510.45% |
| Research & Development | 857.07K | 475.86K | 458.38K | 149.25K | 83.00K | 13.54K | 749.00 | 21.26K | 75.80K |
| General & Administrative | 3.12M | 4.52M | 2.00M | 2.96M | 1.35M | 1.84M | 36.45K | 20.44K | 491.92K |
| Selling & Marketing | 558.60K | 696.82K | 567.93K | 263.55K | 36.47K | 9.49K | 0.00 | 0.00 | 0.00 |
| SG&A | 3.68M | 5.22M | 2.57M | 3.22M | 1.39M | 1.84M | 36.45K | 20.44K | 491.92K |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 4.54M | 5.69M | 3.02M | 3.37M | 1.47M | 1.86M | 36.45K | 20.44K | 519.35K |
| Cost & Expenses | 4.92M | 5.69M | 3.02M | 3.37M | 1.47M | 1.86M | 36.45K | 20.44K | 595.15K |
| Interest Income | 211.60K | 103.55K | 3.32K | 45.87K | 45.88K | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 10.07K | 52.77K | 45.87K | 45.88K | 40.24K | 27.31K | 0.00 | 0.00 |
| Depreciation & Amortization | -466.01K | 5.25M | 2.73M | 3.20M | 1.35M | 892.64K | 1.08K | 1.08K | 2.31K |
| EBITDA | -676.94K | 0.00 | 0.00 | 0.00 | 0.00 | -1.85M | -170.25K | -147.89K | -555.31K |
| EBITDA Ratio | -14.37% | -86,148.73% | -23,398.17% | 0.00% | 0.00% | -92,656.85% | -1,734.11% | -18.75% | -4,472.14% |
| Operating Income | -210.93K | -5.58M | -3.01M | -3.37M | -1.47M | -1.85M | -36.45K | -20.44K | -557.62K |
| Operating Income Ratio | -4.48% | -86,148.73% | -23,398.17% | 0.00% | 0.00% | -92,656.85% | -1,734.11% | -18.75% | -4,490.77% |
| Total Other Income/Expenses | -466.01K | -313.51K | -334.69K | -109.90K | -164.09K | -40.24K | 250.74K | 108.35K | -25.12K |
| Income Before Tax | -676.94K | -5.57M | -3.06M | -3.31M | -1.52M | -1.89M | -36.45K | -20.44K | -582.73K |
| Income Before Tax Ratio | -14.37% | -85,905.87% | -23,808.18% | 0.00% | 0.00% | -94,668.85% | -1,734.11% | -18.75% | -4,693.03% |
| Income Tax Expense | 0.00 | -5.24M | -2.73M | -3.15M | -1.35M | -161.14K | 88.55K | -24.40K | 0.00 |
| Net Income | -676.94K | -5.57M | -3.06M | -3.31M | -1.52M | -1.89M | -36.45K | -20.44K | -582.73K |
| Net Income Ratio | -14.37% | -85,905.87% | -23,808.18% | 0.00% | 0.00% | -94,668.85% | -1,734.11% | -18.75% | -4,693.03% |
| EPS | -0.01 | -0.11 | -0.07 | -0.09 | -0.06 | -0.08 | 0.00 | 0.00 | -0.03 |
| EPS Diluted | -0.01 | -0.11 | -0.07 | -0.09 | -0.06 | -0.08 | 0.00 | 0.00 | -0.03 |
| Weighted Avg Shares Out | 49.90M | 49.01M | 43.74M | 37.31M | 25.29M | 24.99M | 24.99M | 24.99M | 20.91M |
| Weighted Avg Shares Out (Dil) | 49.89M | 49.01M | 43.74M | 37.31M | 25.29M | 24.99M | 24.99M | 24.99M | 20.91M |
MustGrow Receives PMRA Approval to Commence Large Scale Field Trials via NexusBioAg BAT Program
Approval from Health Canada's Pest Management Regulatory Agency (PMRA) to commence large-scale farmer trials. Program to focus on MustGrow's TerraMG™ mustard-derived soil biopesticide technology for use in Canadian canola and pulse crop markets.
MustGrow receives USDA organic certification for TerraSante crop fertilizer
MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF) has achieved a significant milestone by obtaining organic compliance certification from the USDA National Organic Program for its TerraSante crop fertilizer and soil amendment technology. The organic certification, awarded by the Organic Materials Review Institute...
MustGrow Receives USDA Organic Approval for Biological Fertilizer and Soil Amendment Technology
USDA National Organic Program (OMRI Listed ® ) has awarded MustGrow's TerraSante TM Crop Fertilizer and Soil Amendment technology with organic compliance. TerraSante TM is a mustard plant-based technolgy focused on soil and soil microbiome health, nutrient and water use...
MustGrow Announces Participation at Biocontrol Industry Conference and Investor Webinar
Saskatoon, Saskatchewan--(Newsfile Corp. - October 19, 2023) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow") will be participating in next week's Annual Biocontrol Industry Meeting ("ABIM") in Basel, Switzerland from October 23rd to 25th....
MustGrow Announces Investor Relations Agreement with Harbor Access
Saskatoon, Saskatchewan--(Newsfile Corp. - September 12, 2023) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow") is pleased to announce the engagement of Harbor Access LLC ("Harbor Access") to perform investor relations services and activities,...
MustGrow shows efficacy of its plant-based technologies with Janssen PMP agreement expansion
The expansion of MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF)'s postharvest food preservation evaluation agreement with Janssen PMP is further evidence of the efficacy of MustGrow's biological mustard plant-based technologies and another step on the path to commercialization, according to analysts at...
MustGrow expands partnership with Janssen PMP to enhance postharvest food preservation
MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF) has announced an expansion to its existing partnership with Janssen PMP, a division of Janssen Pharmaceutica NV with extensive experience in post-harvest treatments and plant protection. The company said that the existing agreement to test...
MustGrow and Janssen PMP, a division of Janssen Pharmaceutica NV, Announce Significant Project Expansion
Exclusive agreement with Janssen PMP to now include postharvest potatoes and bananas globally, a significant strengthening of existing partnership. Janssen PMP postharvest research, development, and commercialization capabilities have driven expansion.
MustGrow Announces Grant of RSUs and DSUs
Saskatoon, Saskatchewan--(Newsfile Corp. - September 1, 2023) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow"), today announced that the board of directors of the Company authorized and approved the grant of a total of...
MustGrow receives innovation award for natural crop protection solutions
MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF) announced it has won the "AgTech Innovation of the Year" award at the fourth annual AgTech Breakthrough Awards program. AgTech Breakthrough is a leading authority in market intelligence that highlights the premier companies, technologies, and...
Source: https://incomestatements.info
Category: Stock Reports